Literature DB >> 26728842

Myelodysplastic syndrome.

Richard A Wells1, Rena Buckstein2, Jeremy Rezmovitz2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26728842      PMCID： PMC4938687          DOI： 10.1503/cmaj.151077

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Validation of a scoring system to establish the probability of myelodysplastic syndrome in patients with unexplained cytopenias or macrocytosis.

Authors:  J Rauw; R A Wells; A Chesney; M Reis; Liying Zhang; Rena Buckstein
Journal:  Leuk Res       Date:  2011-06-24       Impact factor: 3.156

2.  Revised international prognostic scoring system for myelodysplastic syndromes.

Authors:  Peter L Greenberg; Heinz Tuechler; Julie Schanz; Guillermo Sanz; Guillermo Garcia-Manero; Francesc Solé; John M Bennett; David Bowen; Pierre Fenaux; Francois Dreyfus; Hagop Kantarjian; Andrea Kuendgen; Alessandro Levis; Luca Malcovati; Mario Cazzola; Jaroslav Cermak; Christa Fonatsch; Michelle M Le Beau; Marilyn L Slovak; Otto Krieger; Michael Luebbert; Jaroslaw Maciejewski; Silvia M M Magalhaes; Yasushi Miyazaki; Michael Pfeilstöcker; Mikkael Sekeres; Wolfgang R Sperr; Reinhard Stauder; Sudhir Tauro; Peter Valent; Teresa Vallespi; Arjan A van de Loosdrecht; Ulrich Germing; Detlef Haase
Journal:  Blood       Date:  2012-06-27       Impact factor: 22.113

3.  Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs.

Authors:  Dana E Rollison; Nadia Howlader; Martyn T Smith; Sara S Strom; William D Merritt; Lynn A Ries; Brenda K Edwards; Alan F List
Journal:  Blood       Date:  2008-04-28       Impact factor: 22.113

4.  Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia.

Authors:  Jack M Guralnik; Richard S Eisenstaedt; Luigi Ferrucci; Harvey G Klein; Richard C Woodman
Journal:  Blood       Date:  2004-07-06       Impact factor: 22.113

5.  Guidelines for the diagnosis and management of adult myelodysplastic syndromes.

Authors:  Sally B Killick; Chris Carter; Dominic Culligan; Christopher Dalley; Emma Das-Gupta; Mark Drummond; Helen Enright; Gail L Jones; Jonathan Kell; Juliet Mills; Ghulam Mufti; Jane Parker; Kavita Raj; Alexander Sternberg; Paresh Vyas; David Bowen
Journal:  Br J Haematol       Date:  2013-12-23       Impact factor: 6.998

6.  Health care utilization and mortality among elderly patients with myelodysplastic syndromes.

Authors:  K J Lindquist; M D Danese; J Mikhael; K B Knopf; R I Griffiths
Journal:  Ann Oncol       Date:  2010-11-01       Impact factor: 32.976
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.